SCHEMBL13971346

SCHEMBL13971346

CCCCOc1cc(Br)ccc1/C=N/c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.44
▸ GAA P10253 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MAOB P27338 3/20 0.40
▸ TSHR P16473 1/20 0.39
▸ CCR5 P51681 1/20 0.39
▸ LMNA P02545 4/20 0.39
▸ PDGFRB P09619 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ PTK6 Q13882 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13971180 0.89 HPGD (0.45) HPGDGAAALDH1A1MEN1KMT2A
SCHEMBL14206353 0.88 GAA (0.46) HPGDGAAALDH1A1MEN1KMT2A
SCHEMBL13786439 0.87 MAOB (0.46) HPGDGAAALDH1A1MEN1KMT2A
SCHEMBL14035606 0.87 GAA (0.46) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL14221634 0.85 MAOB (0.46) HPGDGAAALDH1A1MEN1KMT2A
SCHEMBL13971076 0.84 GAA (0.46) HPGDGAAALDH1A1MEN1KMT2A
SCHEMBL14035636 0.82 MAOB (0.40) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL14035601 0.80 CYP19A1 (0.45) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL13956250 0.79 MAOB (0.58) MAPTMAOBCCR5LMNACYP1A2
SCHEMBL13663884 0.78 GAA (0.47) GAAALDH1A1MAPTMAOBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005321-A1 Phenylazetidinone Derivatives MICROBIA, INC. (US) 2009-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005321-A1 Phenylazetidinone Derivatives TYR, AAAS, FANCD2 HPGD 57/4885GAA 15/4885ALDH1A1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback